deferiprone Tablets, film coated 500 mg
Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Available for
Licensing with supply, Distribution only
Comments
Reference Product : Ferriprox
Manufacturer #2748
It is a privately held pharmaceutical company based in southeast Europe that was established in the 1990s to import and introduce pharmaceutical items into medicine. The company began by importing hemophilia and intensive care supplies, as well as immunoglobulin-containing items. To suit market demands, the company has added additional dermatological, cardiological, urological, and surgical goods to its portfolio since then. They now offer a diverse product line that includes not only prescription but also OTC, medical gadgets, and dermo-cosmetics.
Manufacturer usually replies in 7 days
Deferiprone is an iron chelator medication used to treat thalassemia major. Suppliers of deferiprone market it in the form of 500mg and 1000mg oral tablets.
The developer and earliest manufacturer of deferiprone is Apotex Pharmaceuticals, which first introduced the drug into the market in 1994. It is currently approved in over 60 countries worldwide, including but not limited to China, Australia, the U.S., and across Europe. Apotex remains the largest manufacturer and supplier of deferiprone medications globally.
Retail prices per 100 (500mg) tablets of deferiprone are typically around 300 EUR.